Verrill Dana Welcomes Former FDA Counsel Katlin McKelvie Backfield
(July 11, 2018) – Verrill Dana is pleased to welcome attorney Katlin McKelvie Backfield to the firm's nationally recognized Health Care Group. Katlin comes to Verrill Dana with more than 15 years of pharmaceutical regulatory experience, including more than a decade at the Food and Drug Administration.
While at the FDA, Katlin served as Associate Chief Counsel for Drugs in the Office of Chief Counsel and as a Regulatory Counsel in the Division of Drug Marketing, Advertising, and Communications (DDMAC) (now the Office of Prescription Drug Promotion). Prior to joining the FDA, she practiced at Hogan & Hartson LLP (now Hogan Lovells LLP).
Katlin's in-depth experience at the FDA and in private practice will be a valuable asset to the Health Care Group's thriving life sciences and clinical research practice areas. She helps clients navigate the complex pre- and post-approval stages of drug development and address high-stakes FDA regulatory compliance matters. Katlin's areas of focus include, among others, advertising and promotion, manufacturing and inspections, the drug development process (including INDs, BLAs, and NDAs), and post-marketing safety requirements.
Katlin served as a law clerk for the Honorable Douglas P. Woodlock of the U.S. District Court for the District of Massachusetts. She received her law degree from the Georgetown University Law Center and earned her bachelor's degree from Davidson College.